Compounds > 2-methoxyestradiol
Page last updated: 2024-08-24

2-methoxyestradiol and Carcinoma, Epidermoid

2-methoxyestradiol has been researched along with Carcinoma, Epidermoid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, B; Holpuch, A; Koutras, G; Lang, J; Mallery, SR; Nieto, K; Pei, P; Santiago, B; Schwendeman, SP; Spinney, R; Tong, M; Wang, D1
Joubert, A; Lottering, ML; Thaver, V; van Papendorp, D1
Matsui, H; Matsushita, M; Takata, H; Tomizawa, K1
Chen, Z; Pribluda, VS; Ricker, JL; Swartz, GM; Van Waes, C; Yang, XP1

Other Studies

4 other study(ies) available for 2-methoxyestradiol and Carcinoma, Epidermoid

ArticleYear
Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.
    Cancer prevention research (Philadelphia, Pa.), 2017, Volume: 10, Issue:1

    Topics: 2-Methoxyestradiol; Animals; Antibodies, Monoclonal, Humanized; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinogenesis; Carcinoma, Squamous Cell; Cell Differentiation; Cell Line, Tumor; Estradiol; Fenretinide; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Phenotype; Phosphorylation; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor; Tumor Microenvironment; Xenograft Model Antitumor Assays

2017
In vitro effects of 2-methoxyestradiol on cell numbers, morphology, cell cycle progression, and apoptosis induction in oesophageal carcinoma cells.
    Cell biochemistry and function, 2009, Volume: 27, Issue:4

    Topics: 2-Methoxyestradiol; Antimitotic Agents; Apoptosis; Carcinoma, Squamous Cell; Case-Control Studies; Cell Count; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Esophageal Neoplasms; Estradiol; Humans; Receptors, TNF-Related Apoptosis-Inducing Ligand; Tubulin; Tumor Cells, Cultured

2009
2-methoxyestradiol enhances p53 protein transduction therapy-associated inhibition of the proliferation of oral cancer cells through the suppression of NFkappaB activity.
    Acta medica Okayama, 2004, Volume: 58, Issue:4

    Topics: 2-Methoxyestradiol; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cell Membrane; Drug Therapy, Combination; Estradiol; Humans; Mouth Neoplasms; NF-kappa B; Peptides; Recombinant Fusion Proteins; Transcription, Genetic; Tumor Suppressor Protein p53

2004
2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Dec-15, Volume: 10, Issue:24

    Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents, Phytogenic; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Squamous Cell; Carrier Proteins; Caspase 3; Caspase 7; Caspases; Cell Division; Cell Hypoxia; Drug Therapy, Combination; Enzyme Activation; Estradiol; Female; G2 Phase; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Mice, SCID; Microcirculation; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Transcription Factors; Vascular Endothelial Growth Factor A

2004